Schrödinger, Inc. (NASDAQ:SDGR) Receives Consensus Recommendation of “Buy” from Analysts

Schrödinger, Inc. (NASDAQ:SDGRGet Free Report) has been assigned an average rating of “Buy” from the eight analysts that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, six have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $32.29.

Several research analysts recently commented on the stock. Piper Sandler cut their price target on shares of Schrödinger from $50.00 to $45.00 and set an “overweight” rating on the stock in a report on Thursday, February 27th. KeyCorp raised their price target on shares of Schrödinger from $25.00 to $27.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Finally, BMO Capital Markets raised their price target on shares of Schrödinger from $25.00 to $28.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th.

Read Our Latest Stock Analysis on SDGR

Schrödinger Stock Performance

SDGR opened at $21.05 on Friday. The company’s 50 day simple moving average is $22.44 and its 200 day simple moving average is $20.63. Schrödinger has a 1 year low of $16.67 and a 1 year high of $29.15. The stock has a market capitalization of $1.53 billion, a PE ratio of -9.00 and a beta of 1.62.

Schrödinger (NASDAQ:SDGRGet Free Report) last released its earnings results on Wednesday, February 26th. The company reported ($0.55) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.20). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The company had revenue of $88.32 million during the quarter, compared to analyst estimates of $83.20 million. As a group, sell-side analysts expect that Schrödinger will post -2.37 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO Geoffrey Craig Porges sold 5,491 shares of Schrödinger stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $21.76, for a total transaction of $119,484.16. Following the sale, the chief financial officer now owns 27,544 shares in the company, valued at $599,357.44. This trade represents a 16.62 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 8.60% of the company’s stock.

Institutional Trading of Schrödinger

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Point72 Hong Kong Ltd acquired a new stake in Schrödinger in the fourth quarter valued at $27,000. KBC Group NV raised its holdings in Schrödinger by 45.4% in the third quarter. KBC Group NV now owns 2,508 shares of the company’s stock valued at $47,000 after acquiring an additional 783 shares in the last quarter. Paradigm Asset Management Co. LLC acquired a new stake in Schrödinger in the fourth quarter valued at $50,000. Quarry LP raised its holdings in Schrödinger by 1,150.0% in the third quarter. Quarry LP now owns 2,825 shares of the company’s stock valued at $52,000 after acquiring an additional 2,599 shares in the last quarter. Finally, GAMMA Investing LLC raised its holdings in Schrödinger by 87.5% in the fourth quarter. GAMMA Investing LLC now owns 2,796 shares of the company’s stock valued at $54,000 after acquiring an additional 1,305 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Schrödinger Company Profile

(Get Free Report

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

Read More

Analyst Recommendations for Schrödinger (NASDAQ:SDGR)

Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with MarketBeat.com's FREE daily email newsletter.